Key points are not available for this paper at this time.
The risk of complications for transforaminal ESI is greater with particulate corticosteroids. Nonparticulate corticosteroids, which are often recommended as first-line therapy, may have a short duration of effect, and many commercial formulations contain neurotoxic preservatives. The safety profile of ESIs may continue to improve with the development of safer, sterile formulations that reduce the risk of complications while maintaining efficacy.
Building similarity graph...
Analyzing shared references across papers
Loading...
Steven P. Cohen
Emileigh Greuber
Kip Vought
Clinical Journal of Pain
Uniformed Services University of the Health Sciences
Walter Reed National Military Medical Center
Building similarity graph...
Analyzing shared references across papers
Loading...
Cohen et al. (Fri,) studied this question.
www.synapsesocial.com/papers/69d75e71b843b2be9948f6af — DOI: https://doi.org/10.1097/ajp.0000000000000963
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: